Use of Water Ingestion in Small Intestine Ultrasound
NCT07079007 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 55
Last updated 2025-07-22
Summary
Small Intestine Contrast Ultrasonography (SICUS) is an ultrasound-based method that explores bowel loops, and is able to identify wall thickness, intestinal motility, bowel wall vascularity and complications such as stenosis or dilatation. Previous studies have utilised oral ingestion of an oral contrast solution (usually PEG dissolved in a volume of water ranging from 250 to 1000mL), in order to increase the sensitivity of ultrasound, especially in stricture detection. Parameters that have been improved include lumen distension to better delineate bowel wall layers, and improved peristalsis. Diffusion of this technique has been limited, in part due to PEG-based agents being costly, time consuming and are not tolerated well in some individuals. Utilisation of water as oral contrast may improve patient tolerability and therefore increase uptake of water ingested intestinal contrast ultrasound (WICUS) as a technique in routine clinical practice. The investigators aim to study the tolerability and the improvement of image quality utilising water as an oral contrast for intestinal ultrasonography.
Conditions
- Crohn Disease (CD)
- Intestine Ultrasonography
Interventions
- OTHER
-
Water
Patients that meet the inclusion and exclusion criteria would be asked to ingest 1000ml water as part of standard of care.
Sponsors & Collaborators
-
Austin Health
lead OTHER_GOV
Eligibility
- Min Age
- 18 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2025-07-31
- Primary Completion
- 2025-11-30
- Completion
- 2026-02-28
Countries
- Australia
Study Locations
More Related Trials
-
Endoscopic Severity Score of Small Bowel Crohn's Disease With Wireless Capsule Endoscopy
NCT00492791 ·Status: COMPLETED
-
Validation of an IUS Activity Index
NCT05407350 ·Status: UNKNOWN
-
Usefulness of Contrast-enhanced Ultrasound (CEUS) in Crohn's Disease Pediatric Patients
NCT04660136 ·Status: UNKNOWN ·Phase: PHASE4
-
A Study of Safety and Effectiveness of Ustekinumab in Patients With Moderate to Severe Active Crohn's Disease Who Have Been Previously Treated With Anti-TNF Therapy
NCT00771667 ·Status: COMPLETED ·Phase: PHASE2
-
Value of IUS in Predicting Vedolizumab Efficacy and Assessing Transmural Healing in Early Crohn's Disease: A Multicenter, Prospective Study
NCT07093294 ·Status: RECRUITING
-
The IUSS Crohn's Study: A Feasibility Study
NCT03939117 ·Status: COMPLETED
-
Visilizumab for Moderate to Severe Inflammatory, Nonstricturing, Nonpenetrating Crohn's Disease
NCT00267722 ·Status: COMPLETED ·Phase: PHASE2
-
Ultrasound and Proteomics for Guselkumab Response Assessment in Crohn's Disease (UPGRADE).
NCT07246460 ·Status: RECRUITING
-
Utility of Low Intensity Pulsed Ultrasound Stimulation (LIPUS) to Modulate the Release of Mediators Capable of Reflecting the Inflammatory State in the Affected Colonic Tract of Ulcerative Colitis Patients
NCT06569888 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Vagus Nerve Stimulation in Crohn's Disease
NCT02311660 ·Status: UNKNOWN ·Phase: NA
-
Capsule Endoscopy Crohn's Disease Activity Index - Validation Multi Center Study
NCT00596700 ·Status: COMPLETED ·Phase: PHASE3
-
IUS Predicts Guselkumab Efficacy in Patients With Moderate to Severe Crohn's Disease:a Prospective Study
NCT07034664 ·Status: RECRUITING
-
Intestinal Ultrasound for the Evaluation of Pouchitis and Other Outcomes After Ileal Pouch-Anal Anastomosis
NCT06316999 ·Status: COMPLETED ·Phase: NA
-
Visilizumab for Treatment of Perianal Fistulas in Crohn's Disease
NCT00267709 ·Status: COMPLETED ·Phase: PHASE2
-
Comparative Study of Intestinal Color Ultrasound and Capsule Endoscopy in Monitoring Crohn's Disease
NCT05636657 ·Status: UNKNOWN
-
Assessment of Small Bowel Healing in Crohn's Disease Patients Treated With Cimzia Using Wireless Capsule Endoscopy
NCT01053559 ·Status: COMPLETED ·Phase: NA
-
A Study to Observe the Safety and Efficacy of Vedolizumab in Biologically Naive Participants With Ulcerative Colitis (UC) or Crohn´s Disease (CD)
NCT02986724 ·Status: COMPLETED
-
Efficacy and Safety of Oral OPS-2071 in Participants With Crohn's Disease Showing Symptoms of Active Inflammation
NCT03850509 ·Status: TERMINATED ·Phase: PHASE2
-
VSL#3 Versus Placebo in Maintenance of Remission in Crohn's Disease
NCT00114465 ·Status: COMPLETED ·Phase: PHASE4
-
Intraoperative Ultrasound in Crohn's Disease
NCT06388057 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Ultrasound Stiffness Imaging in Crohn's Disease
NCT01666626 ·Status: COMPLETED
-
Role of Intestinal Ultrasound in Treat to Target Strategy in the Management of Inflammatory Bowel Disease : the IUS-TTT Study
NCT06534216 ·Status: ACTIVE_NOT_RECRUITING
-
Contrast Enhanced Ultrasound in Human Crohn's Disease-Lumason
NCT03492944 ·Status: ACTIVE_NOT_RECRUITING
-
Response Assessment in SB CD
NCT03646708 ·Status: ACTIVE_NOT_RECRUITING
-
A follow-on Safety Study in Subjects With Crohn's Disease Who Have Previously Been Withdrawn From the Double-blind Study CDP870-031 [NCT00152490] or CDP870-032 [NCT00152425] Due to an Exacerbation of Crohn's Disease
NCT00160706 ·Status: COMPLETED ·Phase: PHASE3